|
AP2320A
(en)
|
2004-05-12 |
2011-11-07 |
Pfizer Procucts Inc |
Proline derivatives and their use as dipeptidyl peptidase IV inhibitors.
|
|
US20060199853A1
(en)
*
|
2005-02-18 |
2006-09-07 |
Charles Mioskowski |
Analogs of 4-hydroxyisoleucine and uses thereof
|
|
CN101252926A
(zh)
*
|
2005-03-22 |
2008-08-27 |
因诺迪亚有限公司 |
用于预防和治疗肥胖症及相关综合征的化合物与组合物
|
|
CA2599419A1
(en)
|
2005-04-22 |
2006-11-02 |
Alantos Pharmaceuticals Holding, Inc. |
Dipeptidyl peptidase-iv inhibitors
|
|
KR20100114944A
(ko)
*
|
2005-08-11 |
2010-10-26 |
에프. 호프만-라 로슈 아게 |
Ｄｐｐ-ｉｖ 억제제를 포함하는 약학 조성물
|
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
|
WO2007107008A1
(en)
*
|
2006-03-22 |
2007-09-27 |
Innodia Inc. |
Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
US7727978B2
(en)
*
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
GB0713602D0
(en)
*
|
2007-07-12 |
2007-08-22 |
Syngenta Participations Ag |
Chemical compounds
|
|
WO2009037719A1
(en)
*
|
2007-09-21 |
2009-03-26 |
Lupin Limited |
Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors
|
|
JP5305704B2
(ja)
*
|
2008-03-24 |
2013-10-02 |
富士フイルム株式会社 |
新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
|
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
|
WO2010146597A1
(en)
|
2009-06-18 |
2010-12-23 |
Lupin Limited |
2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
|
|
US8999975B2
(en)
*
|
2011-09-19 |
2015-04-07 |
Boehringer Ingelheim International Gmbh |
Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
|
|
SG11201504857SA
(en)
|
2012-12-21 |
2015-07-30 |
Gilead Sciences Inc |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
|
AU2014230814B2
(en)
|
2013-03-14 |
2017-12-21 |
Boehringer Ingelheim International Gmbh |
Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C
|
|
JP6441831B2
(ja)
|
2013-03-14 |
2018-12-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
カテプシンｃの置換２−アザ−ビシクロ［２．２．２］オクタン−３−カルボン酸（ベンジル−シアノ−メチル）−アミド阻害剤
|
|
NO2865735T3
(US07585860-20090908-C00112.png)
|
2013-07-12 |
2018-07-21 |
|
|
|
CA2916993C
(en)
|
2013-07-12 |
2019-01-15 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
|
TWI677489B
(zh)
|
2014-06-20 |
2019-11-21 |
美商基利科學股份有限公司 |
多環型胺甲醯基吡啶酮化合物之合成
|
|
NO2717902T3
(US07585860-20090908-C00112.png)
|
2014-06-20 |
2018-06-23 |
|
|
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
|
WO2016016242A1
(en)
|
2014-08-01 |
2016-02-04 |
Boehringer Ingelheim International Gmbh |
Substituted oxetanes and their use as inhibitors of cathepsin c
|
|
LT3191487T
(lt)
|
2014-09-12 |
2019-10-10 |
Boehringer Ingelheim International Gmbh |
Katepsino c spirocikliniai inhibitoriai
|
|
TWI695003B
(zh)
|
2014-12-23 |
2020-06-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
|
EA201791982A1
(ru)
|
2015-03-09 |
2020-02-17 |
Интекрин Терапьютикс, Инк. |
Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
|
|
PL3277691T3
(pl)
|
2015-04-02 |
2019-07-31 |
Gilead Sciences, Inc. |
Policykliczne związki karbamoilopirydonowe i ich zastosowanie farmaceutyczne
|
|
CN110996951A
(zh)
|
2017-04-03 |
2020-04-10 |
科赫罗斯生物科学股份有限公司 |
治疗进行性核上性麻痹的PPARγ激动剂
|
|
IT201700059292A1
(it)
*
|
2017-05-31 |
2018-12-01 |
Univ Pisa |
Derivati 1,3-diaza-4-ossa-[3.3.1]-biciclici, loro preparazione e uso come medicinale, in particolare per il trattamento del diabete
|
|
CA3108449A1
(en)
|
2018-08-08 |
2020-02-13 |
Sumitomo Dainippon Pharma Co., Ltd. |
Optically active bridged piperidine derivative
|
|
US11369605B2
(en)
|
2018-08-27 |
2022-06-28 |
Sumitomo Dainippon Pharma Co., Ltd. |
Optically active azabicyclo ring derivative
|
